EMOR (Healixa) Return-on-Tangible-Asset: 0.00% (As of . 20)


What is Healixa Return-on-Tangible-Asset?

Healixa EMOR +17.19% Return-on-Tangible-Asset is 0.00% as of . 20.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Healixa's annualized Net Income for the quarter that ended in . 20 was $ Mil. Healixa's average total tangible assets for the quarter that ended in . 20 was $ Mil. Therefore, Healixa's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Healixa's Return-on-Tangible-Asset or its related term are showing as below:

EMOR's Return-on-Tangible-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.43
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Healixa  (OTCPK:EMOR) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Healixa Return-on-Tangible-Asset Related Terms


Healixa Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Healixa's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healixa Return-on-Tangible-Asset Chart

Healixa Annual Data
Trend
Return-on-Tangible-Asset

Healixa Quarterly Data
Return-on-Tangible-Asset

Healixa Return-on-Tangible-Asset Competitor Comparison

For the Health Information Services subindustry, Healixa's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healixa Return-on-Tangible-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Healixa's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Healixa's Return-on-Tangible-Asset falls into.



Healixa Return-on-Tangible-Asset Calculation

Healixa's annualized Return-on-Tangible-Asset for the fiscal year that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+)/ )
=/
= %

Healixa's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (. 20) net income data.

What does a Return-on-Tangible-Asset of 0.00% mean?
Healixa (EMOR) has a Return-on-Tangible-Asset of 0.00% as of . 20. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Healixa and its competitors.
Is Healixa's Return-on-Tangible-Asset too high?
Healixa's current Return-on-Tangible-Asset is 0.00%.
How does Healixa's Return-on-Tangible-Asset compare to competitors?
Healixa's Return-on-Tangible-Asset of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median Return-on-Tangible-Asset is 2.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Healixa and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healixa's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healixa stock overvalued right now?
Healixa (EMOR) has a current Return-on-Tangible-Asset of 0.00%. The current Return-on-Tangible-Asset is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Healixa (EMOR), the current Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Healixa Business Description

Address 273 Knickerbocker Avenue, Bohemia, New York, NY, USA, 11716
Healixa Inc is a technology company focused on building and acquiring disruptive technologies in the health-tech, clean water harvesting, and green-tech industries. Its activities consist mainly of research and development, intellectual property development, engineering validation, pilot deployment, and early-stage commercialization of its technology platforms. The company also focuses on clean water through its Eternal Spring Deposition Water Harvesting technology and on water harvesting and thermal cooling technologies.